{"meta":{"query_hash":"efd72dd0a703","filters":{"venue":"Immuno Oncology Insights"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/efd72dd0a703","api":"https://metacan.xera.ac/api/v1/cohort?venue=Immuno+Oncology+Insights"},"results":[{"id":"W4390679848","doi":"10.18609/ioi.2023.038","title":"Multiomics integration: advancing pediatric cancer immunotherapy","year":2023,"lang":"en","type":"article","venue":"Immuno Oncology Insights","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Immunotherapy; Medicine; Cancer; Cancer immunotherapy; Intensive care medicine; Internal medicine","score_opus":0.019248188408878673,"score_gpt":0.3108157496874054,"score_spread":0.29156756127852673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390679848","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009715828,0.24627897,0.0077633904,0.58978564,0.15082356,0.000033506753,0.0001131891,0.0002504812,0.0039796312],"genre_scores_gemma":[0.014609348,0.34563354,0.009002507,0.18660268,0.43484735,0.000057071025,0.00013512817,0.00016319583,0.008949239],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722064,0.0010045564,0.00030397106,0.00027954488,0.0009743252,0.00021698055],"domain_scores_gemma":[0.98298395,0.010429884,0.0008288806,0.00039928028,0.0032994703,0.002058478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012653065,0.00075655465,0.0007357355,0.0012549028,0.0006285006,0.0051678414,0.0014123202,0.0048266035,0.0019572768],"category_scores_gemma":[0.014287843,0.00039244504,0.00083973876,0.00071864214,0.0015835997,0.004935383,0.0020394963,0.015145722,0.00079528266],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010335812,0.00004090184,0.0011498067,0.0006356912,0.000076961376,0.0004256141,0.00030386724,0.00033337978,0.0008898419,0.012662705,0.710194,0.2731839],"study_design_scores_gemma":[0.000016303282,0.00005827732,0.0006139245,0.0005254416,0.0000470796,0.0006924739,0.00018319672,0.00039360212,0.000504125,0.009787134,0.9871609,0.000017457955],"about_ca_topic_score_codex":0.0010450239,"about_ca_topic_score_gemma":0.0031215746,"teacher_disagreement_score":0.012653065,"about_ca_system_score_codex":0.001438099,"about_ca_system_score_gemma":0.0030282422,"threshold_uncertainty_score":0.066916645},"labels":[],"label_agreement":null}]}